Axon Enterprise, Inc (NASDAQ:AXON) Receives Average Rating of “Moderate Buy” from Analysts

24 Sep 2026, 08:28 by Kim Johansen · The Markets Daily

Shares of Axon Enterprise, Inc (NASDAQ:AXON – Get Free Report) have earned an average recommendation of “Moderate Buy” from the seventeen ratings firms that are presently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and fourteen have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $721.5714.

A number of research analysts recently commented on AXON shares. Citigroup reiterated a “market outperform” rating on shares of Axon Enterprise in a research note on Thursday, September 17th. The Goldman Sachs Group restated a “buy” rating and set a $715.00 price objective on shares of Axon Enterprise in a report on Thursday, August 6th. Barclays increased their target price on Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Morgan Stanley lifted their price target on Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Finally, Citizens Jmp restated a “market outperform” rating and issued a $700.00 price target on shares of Axon Enterprise in a research note on Thursday, June 25th.

Get Our Latest Analysis on Axon Enterprise

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 9,605 shares of Axon Enterprise stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $626.70, for a total value of $6,019,453.50. Following the completion of the sale, the insider owned 97,761 shares in the company, valued at $61,266,818.70. The trade was a 8.95% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of the business’s stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $480.45, for a total transaction of $488,617.65. Following the completion of the sale, the insider directly owned 56,264 shares of the company’s stock, valued at $27,032,038.80. This represents a 1.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 67,397 shares of company stock worth $38,160,884 over the last ninety days. Corporate insiders own 4.20% of the company’s stock.

Institutional Investors Weigh In On Axon Enterprise

A number of hedge funds and other institutional investors have recently made changes to their positions in AXON. State Street Corp grew its position in Axon Enterprise by 5,700.2% during the second quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock worth $119,724,905,000 after buying an additional 209,879,882 shares in the last quarter. Envestnet Asset Management Inc. grew its holdings in shares of Axon Enterprise by 18,050.2% during the 2nd quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock worth $7,400,094,000 after purchasing an additional 13,127,348 shares in the last quarter. BlackRock Inc. grew its holdings in shares of Axon Enterprise by 4.3% during the 2nd quarter. BlackRock Inc. now owns 8,334,551 shares of the biotechnology company’s stock worth $4,672,432,000 after purchasing an additional 345,365 shares in the last quarter. The Manufacturers Life Insurance Company increased its position in shares of Axon Enterprise by 8,432.6% in the second quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock worth $1,983,414,000 after purchasing an additional 3,496,493 shares during the period. Finally, Geode Capital Management LLC increased its position in shares of Axon Enterprise by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 2,226,159 shares of the biotechnology company’s stock worth $1,265,657,000 after purchasing an additional 35,544 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise News Roundup

Here are the key news stories impacting Axon Enterprise this week:

Positive Sentiment: Long-term contract renewal supports recurring revenue. Chattanooga’s city council renewed its contract with Axon for five years, reinforcing demand for the company’s public-safety hardware and software platform. Chattanooga City Council renews five-year contract with Axon Enterprise
Positive Sentiment: Expansion of surveillance products could broaden Axon’s footprint. The Los Angeles Police Department’s approval of a license-plate-reader pilot, alongside a proposed Axon technology deal, highlights potential growth in connected public-safety solutions. LAPD ALPR Pilot Approved as Axon Tech Deal Heads to City Council
Positive Sentiment: Customer adoption remains visible internationally. Montreal police spent about $20,000 on an Axon robot and related accessories over five months, offering a small but potentially useful reference point for demand for Axon’s emerging robotics products. Montreal police spend $20,000 on Axon robot and accessories over five months
Neutral Sentiment: Axon avoided a Senate hearing but may face continued political scrutiny. Axon and Flock executives did not attend Senator Josh Hawley’s hearing on surveillance technology; Hawley indicated subpoenas could be considered, keeping regulatory and reputational risks in focus. Flock, Axon dodge Senate hearing after invite from Chair Josh Hawley
Negative Sentiment: $1.15 billion in zero-interest convertible senior notes raises dilution and leverage concerns. Although the financing avoids cash interest expense, future conversion could dilute existing shareholders and the debt adds to balance-sheet risk—especially for a richly valued growth stock. Axon Enterprise Raises $1.15 Billion Through Zero-Interest Convertible Senior Notes Due 2031
Negative Sentiment: Valuation, margin, and debt concerns are weighing on sentiment. Recent commentary points to pressure on profitability and financing obligations, while AXON’s elevated valuation leaves the stock particularly sensitive to slower growth or weaker margins. Axon Enterprise stock slips as margins and debt pressure sentiment

Axon Enterprise Trading Down 1.9%

AXON stock opened at $450.61 on Thursday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80. The company has a fifty day moving average price of $542.03 and a two-hundred day moving average price of $484.01. Axon Enterprise has a one year low of $339.01 and a one year high of $789.29. The stock has a market cap of $36.61 billion, a price-to-earnings ratio of 186.98, a price-to-earnings-growth ratio of 8.65 and a beta of 1.40.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.04. The company had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company’s revenue was up 35.3% on a year-over-year basis. During the same period in the prior year, the firm earned $2.12 earnings per share. Equities analysts anticipate that Axon Enterprise will post 2.12 EPS for the current year.

Axon Enterprise Company Profile

(Get Free Report)

Axon Enterprise, Inc develops technology and equipment for law enforcement, public safety and other government agencies. Its product portfolio includes TASER energy weapons, body-worn cameras, in-car cameras and related connected devices designed to support safer interactions, improve transparency and collect operational data.